Since the beginning of the COVID-19 pandemic, decentralization has emerged as one of the fastest-growing trends in the industry. However, the adoption of decentralization has varied greatly between the clinical trials different therapeutic areas carry out, and oncology specifically, often regarded as having the most expensive and complex trials, presents a unique set of challenges researchers are looking to alleviate through decentralization and integrating digital solutions.
ZS experts will discuss the current challenges oncology trials face, with a focus on how decentralization is playing a key role in the post-pandemic era. We’ll also discuss specific opportunities where the industry can look to improve greater patient accessibility and reduce patient burden.
In this webinar, we’ll discuss:
- How decentralization is shaping the future of oncology trials
- Opportunities and examples for decentralization in oncology trials
- Opinions from key opinion leaders on the future of decentralized clinical trials